BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 27611301)

  • 1. Actigraphy in Patients With Major Depressive Disorder Undergoing Repetitive Transcranial Magnetic Stimulation: An Open Label Pilot Study.
    Nishida M; Kikuchi S; Nisijima K; Suda S
    J ECT; 2017 Mar; 33(1):36-42. PubMed ID: 27611301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
    Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
    Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
    Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
    Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in hypersomnia with high frequency repetitive transcranial magnetic stimulation in depressed adolescents: Preliminary evidence from an open-label study.
    Sonmez AI; Kucuker MU; Lewis CP; Kolla BP; Doruk Camsari D; Vande Voort JL; Schak KM; Kung S; Croarkin PE
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109763. PubMed ID: 31634515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Adults with Autism and Major Depressive Disorder Using Transcranial Magnetic Stimulation: An Open Label Pilot Study.
    Gwynette MF; Lowe DW; Henneberry EA; Sahlem GL; Wiley MG; Alsarraf H; Russo SB; Joseph JE; Summers PM; Lohnes L; George MS
    Autism Res; 2020 Mar; 13(3):346-351. PubMed ID: 31944611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive Effects of Repetitive Transcranial Magnetic Stimulation With a 2-Coil Device in Treatment-Resistant Major Depressive Disorder.
    Kavanaugh BC; Aaronson ST; Clarke GN; Holtzheimer PE; Johnson CW; McDonald WM; Schneider MB; Carpenter LL
    J ECT; 2018 Dec; 34(4):258-265. PubMed ID: 29613944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localized potentiation of sleep slow-wave activity induced by prefrontal repetitive transcranial magnetic stimulation in patients with a major depressive episode.
    Saeki T; Nakamura M; Hirai N; Noda Y; Hayasaka S; Iwanari H; Hirayasu Y
    Brain Stimul; 2013 May; 6(3):390-6. PubMed ID: 22964349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive safety of dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression.
    Schulze L; Wheeler S; McAndrews MP; Solomon CJ; Giacobbe P; Downar J
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1213-26. PubMed ID: 27157074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, Safety and Tolerability of Augmentative rTMS in Treatment of Major Depressive Disorder (MDD): A Prospective Cohort Study in Croatia.
    Filipcic I; Milovac Z; Sucic S; Gajsak T; Filipcic IS; Ivezic E; Aljinovic V; Orgulan I; Penic SZ; Bajic Z
    Psychiatr Danub; 2017 Mar; 29(1):31-38. PubMed ID: 28291972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic Resonance Imaging-Guided, Open-Label, High-Frequency Repetitive Transcranial Magnetic Stimulation for Adolescents with Major Depressive Disorder.
    Wall CA; Croarkin PE; Maroney-Smith MJ; Haugen LM; Baruth JM; Frye MA; Sampson SM; Port JD
    J Child Adolesc Psychopharmacol; 2016 Sep; 26(7):582-9. PubMed ID: 26849202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open-label feasibility study of repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant depression in the New Zealand healthcare context.
    Godfrey KE; Muthukumaraswamy SD; Stinear CM; Hoeh NR
    N Z Med J; 2019 Oct; 132(1504):46-55. PubMed ID: 31647794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: an open label trial.
    McGirr A; Van den Eynde F; Tovar-Perdomo S; Fleck MP; Berlim MT
    J Affect Disord; 2015 Mar; 173():216-20. PubMed ID: 25462419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot Study of Accelerated Low-Frequency Right-Sided Transcranial Magnetic Stimulation for Treatment-Resistant Depression.
    Tor PC; Gálvez V; Goldstein J; George D; Loo CK
    J ECT; 2016 Sep; 32(3):180-2. PubMed ID: 26909825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equivalent beneficial effects of unilateral and bilateral prefrontal cortex transcranial magnetic stimulation in a large randomized trial in treatment-resistant major depression.
    Fitzgerald PB; Hoy KE; Singh A; Gunewardene R; Slack C; Ibrahim S; Hall PJ; Daskalakis ZJ
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):1975-84. PubMed ID: 23663510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency repetitive transcranial magnetic stimulation treatment for major depression: Dissociated effects on psychopathology and neurocognition.
    Tovar-Perdomo S; McGirr A; Van den Eynde F; Rodrigues Dos Santos N; Berlim MT
    J Affect Disord; 2017 Aug; 217():112-117. PubMed ID: 28407553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of unilateral and bilateral prefrontal cortex transcranial magnetic stimulation in treatment-resistant major depression.
    Fitzgerald PB; Hoy K; Gunewardene R; Slack C; Ibrahim S; Bailey M; Daskalakis ZJ
    Psychol Med; 2011 Jun; 41(6):1187-96. PubMed ID: 20925972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of the repetitive transcranial magnetic stimulation on sleep quality in depression.
    Antczak JM; Poleszczyk A; Wichniak A; Rakowicz M; Parnowski TJ
    Psychiatr Pol; 2017 Oct; 51(5):845-857. PubMed ID: 29289965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dorsomedial prefrontal cortex repetitive transcranial magnetic stimulation for treatment-refractory major depressive disorder: A three-arm, blinded, randomized controlled trial.
    Dunlop K; Sheen J; Schulze L; Fettes P; Mansouri F; Feffer K; Blumberger DM; Daskalakis ZJ; Kennedy SH; Giacobbe P; Woodside B; Downar J
    Brain Stimul; 2020; 13(2):337-340. PubMed ID: 31711880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two Versus One High-Frequency Repetitive Transcranial Magnetic Stimulation Session per Day for Treatment-Resistant Depression: A Randomized Sham-Controlled Trial.
    Theleritis C; Sakkas P; Paparrigopoulos T; Vitoratou S; Tzavara C; Bonaccorso S; Politis A; Soldatos CR; Psarros C
    J ECT; 2017 Sep; 33(3):190-197. PubMed ID: 28072660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of high-frequency repetitive transcranial magnetic stimulation on major depressive disorder in patients with Parkinson's disease.
    Shin HW; Youn YC; Chung SJ; Sohn YH
    J Neurol; 2016 Jul; 263(7):1442-8. PubMed ID: 27178002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.